Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.665, 2012-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Musculoskeletal disorders: substantial economic burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 323, 2001-01 ,pp. :
Substantial impact of US nonreimbursed care
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 440, 2003-01 ,pp. :
Economic burden of MRSA-related NP substantial
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. :
Widespread tenofovir gel use has substantial impact in South Africa
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 631, 2011-01 ,pp. :